A beta-lactamase-producing Branhamella catarrhalis was isolated in pure culture from the right middle ear aspiration of an otitis media in a 3-month-old girl. The patient responded well to cefamandole treatment.
Otitis media caused by Branhamella catarrhalis has been reported infrequently (3, 7) . The role of this organism in middle ear infections was often underassessed, because the patients responded well to ampicillin treatment and the organism was less invasive. However, the prevalence of otitis media caused by this organism sometimes was ranked just below Streptococcus pneumoniae and Haemophilus influenza according to some reports (2, 4, 6 the end of the day 5 of treatment, she was found to be afebrile and was discharged on erythromycin after a definite improvement.
B. catarrhalis was isolated in pure culture from the right middle ear aspiration and nasopharyngeal swab; it also occurred as the predominant isolate in a mixed normal flora from the throat specimen. This gram-negative diplococcus appeared in slightly whitish colonies on blood agar plates and did not grow on MacConkey agar plates. It was a glucose nonoxidizer and positive for phenylalanine deaminase and nitrate reduction. Other biochemical tests were done and correlated well with the reactions cited in the revised King's chart (12) . The minimum inhibitory concentrations of various antibiotics were determined in Mueller-Hinton broth by the tube dilution method with an inoculum of approximately 105 colony-forming units per ml.
The organism was susceptible to erythromycin, kanamycin, tetracycline, and cefamandole with minimum inhibitory concentrations of 0.25, 0.5, 0.25, and 8 ig/ml, respectively. The minimum inhibitory concentrations for penicillin and ampicillin were 4 and 2 ,ug/ml, respectively. As determined by using a chromogenic cephalosporin substrate (10) , this organism produced betalactamase and was confirmed as a beta-lactamase-producing B. catarrhalis by Guido Controni, Children's Hospital, Washington, D.C. In retrospect, it is interesting to note that even though the minimum inhibitory concentration of cefamandole to this organism was as high as B. catarrhalis has been shown previously to be 100% sensitive to ampicillin (7) . However, with increasing use of oral penicillins, the frequency of beta-lactamase-producing B. catarrhalis infections will be expected to rise, because this organism is known as one of the normal oral flora. In addition, the increase in penicillin-resistant strains among other commensal bacteria, such as Haemophilus sp., Streptococcus viridans, and Bacteroides melaninogenicus (1, 5, 8, 11) , is the ultimate problem for current standard therapy and deserves further investigation.
